Effector Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for EFTR

Based on 2 analysts offering 12 month price targets for Effector Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell EFTR stock?

Based on 2 analysts offering ratings for Effector Therapeutics Inc.
Strong Buy
0 analysts 0%
2 analysts 100%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EFTR stock forecasts and price targets.

EFTR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Credit Suisse
Bottom 8%
JMP Securities
Bottom 5%

1 of 1

EFTR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus

Effector Therapeutics Stock Forecast FAQ

Is Effector Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: EFTR) stock is to Buy EFTR stock.

Out of 2 analysts, 0 (0%) are recommending EFTR as a Strong Buy, 2 (100%) are recommending EFTR as a Buy, 0 (0%) are recommending EFTR as a Hold, 0 (0%) are recommending EFTR as a Sell, and 0 (0%) are recommending EFTR as a Strong Sell.

If you're new to stock investing, here's how to buy Effector Therapeutics stock.

What is EFTR's Price Target?

According to 2 Wall Street analysts that have issued a 1 year EFTR price target, the average EFTR price target is $4.00, with the highest EFTR stock price forecast at $7.00 and the lowest EFTR stock price forecast at $1.00.

On average, Wall Street analysts predict that Effector Therapeutics's share price could reach $4.00 by Mar 9, 2024. The average Effector Therapeutics stock price prediction forecasts a potential upside of 1,001.93% from the current EFTR share price of $0.36.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.